Mundipharma has announced that Mr Marc Princen has joined the Mundipharma network of independently associated companies as the Global CEO, effective June 1, 2020. 
Mr Princen will lead the company’s global strategic and operational matters, focusing on seamless execution of the 2020-2023 Business Plan.
Speaking of the appointment, Mr Jacques Theurillat, Chairman, said, “Mr Princen is a highly proven pharmaceutical executive with a strong track record at leading pharma companies such as Schering-Plough, Merck & Co, Takeda and Allergan. He is widely recognised for his expertise in business change and transformation and joins us at an important moment as we continue our evolution as an organization. I wish him every success in his role with us.”
Mr Princen is joining Mundipharma from Allergan International, where he was the President and EVP, International Business. He has more than 30 years cross-functional experience in the pharmaceutical Industry with expertise spanning commercial, marketing, business development and management. He holds a Bachelor in Physiotherapy degree from Katholieke Universiteit in Leuven, Belgium.

In his new role, Mr Princen will be responsible for all of Mundipharma’s strategic and operational matters globally.